David Bonsall

13.4k total citations · 2 hit papers
35 papers, 2.6k citations indexed

About

David Bonsall is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, David Bonsall has authored 35 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 17 papers in Epidemiology and 11 papers in Virology. Recurrent topics in David Bonsall's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (10 papers) and Hepatitis B Virus Studies (9 papers). David Bonsall is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (10 papers) and Hepatitis B Virus Studies (9 papers). David Bonsall collaborates with scholars based in United Kingdom, United States and South Africa. David Bonsall's co-authors include Christophe Fraser, Lucie Abeler‐Dörner, Michael Parker, Chris Wymant, Luca Ferretti, Michelle Kendall, Anel Nurtay, Lele Zhao, Myra O. McClure and David Muir and has published in prestigious journals such as Nature, Science and Nature Communications.

In The Last Decade

David Bonsall

33 papers receiving 2.5k citations

Hit Papers

Quantifying SARS-CoV-2 transmission suggests epidemic con... 2020 2026 2022 2024 2020 2021 500 1000 1.5k

Peers

David Bonsall
Comparison fields: 5 of 136
  • Modeling and Simulation 1.0k
  • Information Systems 893
  • Infectious Diseases 784
  • Epidemiology 707
  • Sociology and Political Science 492
Replace Christian L. Althaus with:
Christian L. Althaus Switzerland
Ken Eames United Kingdom
Jonathan M. Read United Kingdom
Chris Wymant United Kingdom
Magdalena Rosińska Poland
Vernon J. Lee Singapore
Malik Sallam Jordan
Shengjie Lai China
Viktor von Wyl Switzerland
Julien Riou France
Christian L. Althaus Switzerland View profile →
Citations per field, relative to David Bonsall
David Bonsall · 1×
Citations per year, relative to David Bonsall
David Bonsall · 1×

Countries citing papers authored by David Bonsall

Since Specialization
Citations

This map shows the geographic impact of David Bonsall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bonsall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bonsall more than expected).

Fields of papers citing papers by David Bonsall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bonsall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bonsall. The network helps show where David Bonsall may publish in the future.

Co-authorship network of co-authors of David Bonsall

This figure shows the co-authorship network connecting the top 25 collaborators of David Bonsall. A scholar is included among the top collaborators of David Bonsall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bonsall. David Bonsall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 20
3 8
4 1
5 3
6 63
7
The epidemiological impact of the NHS COVID-19 app breakdown →
163
8
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing breakdown →
1519
9 18
10 56
11 149
12
HIV genotyping and phylogenetics in the HPTN 071 (PopART) study: validation of a high-throughput sequencing assay for viral load quantification, genotyping, resistance testing and high-resolution transmission networking
0
13 70
14 7
15 50
16
Resistance analysis of genotype 3 HCV indicates subtypes inherently resistant to NS5A inhibitors.
3
17 84
18 17
19 58
20 135

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026